Ignite Creation Date:
2024-05-06 @ 1:22 PM
Last Modification Date:
2024-10-26 @ 1:13 PM
Study NCT ID:
NCT04006288
Status:
COMPLETED
Last Update Posted:
2023-04-26
First Post:
2019-06-25
Brief Title:
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
Sponsor:
University of Florida
Organization:
University of Florida
Organization Data
Organization:
University of Florida
Class:
OTHER
Study ID:
IIS-RIVA02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Florida
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen LP | INDUSTRY |